DeVivo MJ, Krause JS, Lammertse DP. Recent trends in mortality and causes of death among persons with spinal cord injury. Arch Phys Med Rehabil. 1999;80:1411–1419.
,
Recent trends in mortality and causes of death among persons with spinal cord injury
, Arch Phys Med Rehabil.
, vol. 80
(pg. 1411
-1419
) Whiteneck GG, Charlifue SW, Frankel HL, et al. Mortality, morbidity, and psychosocial outcomes of persons spinal cord injured more than 20 years ago. Paraplegia. 1992;30(9):617–630.
,
Mortality, morbidity, and psychosocial outcomes of persons spinal cord injured more than 20 years ago
, Paraplegia.
, vol. 30
(pg. 617
-630
) Warburton D , Krassioukov A , Sproule S. Cardiovascular health and exercise rehabilitation in spinal cord injury. Top Spinal Cord Inj Rehabil. 2007;13:98–122.
,
Cardiovascular health and exercise rehabilitation in spinal cord injury
, Top Spinal Cord Inj Rehabil.
, vol. 13
(pg. 98
-122
) Yekutiel M, Brooks ME, Ohry A, Yarom J, Carel R. The prevalence of hypertension, ischaemic heart disease and diabetes in traumatic spinal cord injured patients and amputees. Paraplegia. 1989;27(1):58–62.
,
The prevalence of hypertension, ischaemic heart disease and diabetes in traumatic spinal cord injured patients and amputees
, Paraplegia.
, vol. 27
(pg. 58
-62
) Groah SL, Weitzenkamp D, Sett P, Soni B, Savic G. The relationship between neurological level of injury and symptomatic cardiovascular disease risk in the aging spinal injured. Spinal Cord. 2001;39(6):310–317.
,
The relationship between neurological level of injury and symptomatic cardiovascular disease risk in the aging spinal injured
, Spinal Cord.
, vol. 39
(pg. 310
-317
) Gilbert ON, Croffoot JR, Taylor AJ, Nash MS, Schomer K, Groah S. Serum lipid concentrations among persons with spinal cord injury: A systematic review and meta-analysis of the literature. Atherosclerosis. 2014;232(2):305–312.
,
Serum lipid concentrations among persons with spinal cord injury: A systematic review and meta-analysis of the literature
, Atherosclerosis.
, vol. 232
(pg. 305
-312
) Bauman WA, Kahn NN, Grimm DR, Spungen AM. Risk factors for atherogenesis and cardiovascular autonomic function in persons with spinal cord injury. Spinal Cord. 1999;37:601–616.
,
Risk factors for atherogenesis and cardiovascular autonomic function in persons with spinal cord injury
, Spinal Cord.
, vol. 37
(pg. 601
-616
) Groah SL, Nash MS, Ward EA, et al. Cardiometabolic risk in community-dwelling persons with chronic spinal cord injury. J Cardiopulm Rehabil Prevent. 2011;31(2):73–80.
,
Cardiometabolic risk in community-dwelling persons with chronic spinal cord injury
, J Cardiopulm Rehabil Prevent.
, vol. 31
(pg. 73
-80
) Laughton GE, Buchholz AC, Martin Ginis KA, Goy RE. Lowering body mass index cutoffs better identifies obese persons with spinal cord injury. Spinal Cord. 2009;47(10):757–762.
,
Lowering body mass index cutoffs better identifies obese persons with spinal cord injury
, Spinal Cord.
, vol. 47
(pg. 757
-762
) Wilt TJ, Carlson KF, Goldish GD, et al. Carbohydrate and lipid disorders and relevant considerations in persons with spinal cord injury. Evid Rep Technol Assess. 2008;163:1–95.
,
Carbohydrate and lipid disorders and relevant considerations in persons with spinal cord injury
, Evid Rep Technol Assess.
, vol. 163
(pg. 1
-95
) Nash M, Gilbert O, Kressler J, Taylor A. Cardiometabolic Panel. Presented at: The State of the Science of Prevention and Management of Secondary Health Conditions in People After Spinal Cord Injury; 2013; Chicago, Illinois.
,
Cardiometabolic Panel.
Tinsley EA, Ballard P, Libin A. Body composition. Presented at: The State of the Science of Prevention and Management of Secondary Health Conditions in People after Spinal Cord Injury; 2013; Chicago, Illinois.
,
Body composition.
Bigaard J, Frederiksen K, Tjønneland A, et al. Body fat and fat-free mass and all-cause mortality. Obesity. 2004;12(7):1042–1049.
,
Body fat and fat-free mass and all-cause mortality
, Obesity.
, vol. 12
(pg. 1042
-1049
) Bauman WA, Spungen AM. Coronary heart disease in individuals with spinal cord injury: assessment of risk factors. Spinal Cord. 2008;46(7):466–476.
,
Coronary heart disease in individuals with spinal cord injury: assessment of risk factors
, Spinal Cord.
, vol. 46
(pg. 466
-476
) Liang H, Chen D, Wang Y, Rimmer JH, Braunschweig CL. Different risk factor patterns for metabolic syndrome in men with spinal cord injury compared with able-bodied men despite similar prevalence rates. Arch Phys Med Rehabil. 2007;88(9):1198–1204.
,
Different risk factor patterns for metabolic syndrome in men with spinal cord injury compared with able-bodied men despite similar prevalence rates
, Arch Phys Med Rehabil.
, vol. 88
(pg. 1198
-1204
) Gater DR, Clasey JL. Body composition assessment in spinal cord injury clinical trials. Top Spinal Cord Inj Rehabil. 2006;11(3):36–49.
,
Body composition assessment in spinal cord injury clinical trials
, Top Spinal Cord Inj Rehabil.
, vol. 11
(pg. 36
-49
) Heymsfield SB, Lichtman S, Baumgartner RN, et al. Body composition of humans: Comparison of two improved four-compartment models that differ in expense, technical complexity, and radiation exposure. Am J Clin Nutr. 1990;52(1):52–58.
,
Body composition of humans: Comparison of two improved four-compartment models that differ in expense, technical complexity, and radiation exposure
, Am J Clin Nutr.
, vol. 52
(pg. 52
-58
) Eknoyan G. Adolphe Quetelet (1796–1874)—the average man and indices of obesity. Nephrol Dial Transplant. 2008;23(1):47–51.
,
Adolphe Quetelet (1796–1874)—the average man and indices of obesity
, Nephrol Dial Transplant.
, vol. 23
(pg. 47
-51
) World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO consultation. Geneva: Author; 2000.
,
World Health Organization
, Obesity: Preventing and Managing the Global Epidemic. Report of a WHO consultation.
Taylor AE, Ebrahim S, Ben-Shlomo Y, et al. Comparison of the associations of body mass index and measures of central adiposity and fat mass with coronary heart disease, diabetes, and all-cause mortality: a study using data from 4 UK cohorts. Am J Clin Nutr. 2010;91(3):547–556.
,
Comparison of the associations of body mass index and measures of central adiposity and fat mass with coronary heart disease, diabetes, and all-cause mortality: a study using data from 4 UK cohorts
, Am J Clin Nutr.
, vol. 91
(pg. 547
-556
) Gater DR Jr. Obesity after spinal cord injury. Phys Med Rehabil Clin N Am. 2007;18(2):333–351, vii.
,
Obesity after spinal cord injury
, Phys Med Rehabil Clin N Am.
, vol. 18
(pg. 333
-351
) Groah SL, Nash MS, Ljungberg IH, et al. Nutrient intake and body habitus after spinal cord injury: An analysis by sex and level of injury. J Spinal Cord Med. 2009;32(1):25–33.
,
Nutrient intake and body habitus after spinal cord injury: An analysis by sex and level of injury
, J Spinal Cord Med.
, vol. 32
(pg. 25
-33
) Laughton GE, Buchholz AC, Martin Ginis KA, et al. Lowering body mass index cutoffs better identifies obese persons with spinal cord injury. Spinal Cord. 2009;47:757–762.
,
Lowering body mass index cutoffs better identifies obese persons with spinal cord injury
, Spinal Cord.
, vol. 47
(pg. 757
-762
) National Heart, Lung, and Blood Institute in cooperation with The National Institute of Diabetes and Digestive and Kidney Diseases. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. Bethesda, MD: National Institutes of Health;1998.
,
National Heart, Lung, and Blood Institute in cooperation with The National Institute of Diabetes and Digestive and Kidney Diseases
, Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report.
Libin A, TinsleyEA, Nash MS, et al. Cardiometabolic risk clustering in spinal cord injury: Results of exploratory factor analysis. Top Spinal Cord Inj Rehabil. 2013;19(3):183–194.
,
Cardiometabolic risk clustering in spinal cord injury: Results of exploratory factor analysis
, Top Spinal Cord Inj Rehabil.
, vol. 19
(pg. 183
-194
) D’Agostino RBS, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: The Framingham Heart Study. Circulation. 2008;117(6):743–753.
,
General cardiovascular risk profile for use in primary care: The Framingham Heart Study
, Circulation.
, vol. 117
(pg. 743
-753
) Wierzbicki AS, Twomey PJ, Reynolds TM. Cardiovascular risk assessment. Lancet. 2005;365(9467):1305–1306.
,
Cardiovascular risk assessment
, Lancet.
, vol. 365
(pg. 1305
-1306
) Groah SL, Libin A, LauderdaleM, Kroll T, DeJong G, Hsieh J. Beyond the evidence-based practice paradigm to achieve best practice in rehabilitation medicine: A clinical review. Phys Med Rehabil. 2009;1(10):941–950.
,
Beyond the evidence-based practice paradigm to achieve best practice in rehabilitation medicine: A clinical review
, Phys Med Rehabil.
, vol. 1
(pg. 941
-950
) Barnett SD, Heinemann AW, Libin A, et al. Small N designs for rehabilitation research. J Rehabil Res Dev. 2012;49(1):175–186.
,
Small N designs for rehabilitation research
, J Rehabil Res Dev.
, vol. 49
(pg. 175
-186
) Bauman WA, Adkins RH, Spungen AM, Kemp BJ, Waters RL. The effect of residual neurological deficit on serum lipoproteins in individuals with chronic spinal cord injury. Spinal Cord. 1998;36(1):13–17.
,
The effect of residual neurological deficit on serum lipoproteins in individuals with chronic spinal cord injury
, Spinal Cord.
, vol. 36
(pg. 13
-17
) Demirel S, Demirel G, Tukek T, Erk O, Yilmaz H. Risk factors for coronary heart disease in patients with spinal cord injury in Turkey. Spinal Cord. 2001;39(3):134–138.
,
Risk factors for coronary heart disease in patients with spinal cord injury in Turkey
, Spinal Cord.
, vol. 39
(pg. 134
-138
) Heldenberg D, Rubinstein A, Levtov O, Werbin B, Tamir I. Serum lipids and lipoprotein concentrations in young quadriplegic patients. Atherosclerosis. 1981;39(2):163–167.
,
Serum lipids and lipoprotein concentrations in young quadriplegic patients
, Atherosclerosis.
, vol. 39
(pg. 163
-167
) Liang H, Chen D, Wang Y, Rimmer JH, Braunschweig CL. Different risk factor patterns for metabolic syndrome in men with spinal cord injury compared with able-bodied men despite similar prevalence rates. Arch Phys Med Rehabil. 2007;88(9):1198–1204.
,
Different risk factor patterns for metabolic syndrome in men with spinal cord injury compared with able-bodied men despite similar prevalence rates
, Arch Phys Med Rehabil.
, vol. 88
(pg. 1198
-1204
) Nikkila EA, Kuusi T, Myllynen P. High density lipoprotein and apolipoprotein A-i during physical inactivity. Demonstration at low levels in patients with spine fracture. Atherosclerosis. 1980;37(3):457–462.
,
High density lipoprotein and apolipoprotein A-i during physical inactivity. Demonstration at low levels in patients with spine fracture
, Atherosclerosis.
, vol. 37
(pg. 457
-462
) Schmid A, Halle M, Stutzle C, et al. Lipoproteins and free plasma catecholamines in spinal cord injured men with different injury levels. Clin Physiol. 2000;20(4):304–310.
,
Lipoproteins and free plasma catecholamines in spinal cord injured men with different injury levels
, Clin Physiol.
, vol. 20
(pg. 304
-310
) Wang Y-H, Chen S-Y, Wang T-D, Hwang B-S, Huang T-S, Su T-C. The relationships among serum glucose, albumin concentrations and carotid atherosclerosis in men with spinal cord injury. Atherosclerosis. 2009;206(2):528–534.
,
The relationships among serum glucose, albumin concentrations and carotid atherosclerosis in men with spinal cord injury
, Atherosclerosis.
, vol. 206
(pg. 528
-534
) Zlotolow SP, Levy E, Bauman WA. The serum lipoprotein profile in veterans with paraplegia: The relationship to nutritional factors and body mass index. J Am Paraplegia Soc. 1992;15(3):158–162.
,
The serum lipoprotein profile in veterans with paraplegia: The relationship to nutritional factors and body mass index
, J Am Paraplegia Soc.
, vol. 15
(pg. 158
-162
) Di Angelantonio E, Sarwar N, Perry P, et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;302(18):1993–2000.
,
Major lipids, apolipoproteins, and risk of vascular disease
, JAMA.
, vol. 302
(pg. 1993
-2000
) Emerging Risk Factors Collaboration; Angelantonio ED, Sarwar N, Perry P. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;302:1993–2000.
,
Major lipids, apolipoproteins, and risk of vascular disease
, JAMA.
, vol. 302
(pg. 1993
-2000
) Lewington S, Whitlock G, Clarke R, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: A meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 2007;370(9602):1829–1839.
,
Blood cholesterol and vascular mortality by age, sex, and blood pressure: A meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths
, Lancet.
, vol. 370
(pg. 1829
-1839
) Adult Treatment Panel III. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Final Report. Bethesda, MD: National Cholesterol Education Program; 2002.
,
Adult Treatment Panel III.
, Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Final Report.
National Cholesterol Education Program. Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). Circulation. 1994;1333–1445.
,
National Cholesterol Education Program. Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II)
, Circulation.
(pg. 1333
-1445
) Wilson PWF, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998:1837–1847.
,
Prediction of coronary heart disease using risk factor categories
, Circulation.
(pg. 1837
-1847
) International Diabetes Federation. The IDF Consensus Worldwide Definition of the Metabolic Syndrome. Brussels, Belgium: Author; 2006.
,
International Diabetes Federation
, The IDF Consensus Worldwide Definition of the Metabolic Syndrome.
Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 1989;79(1):8–15.
,
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies
, Circulation.
, vol. 79
(pg. 8
-15
) Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation. 1990;82(2):495–506.
,
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
, Circulation.
, vol. 82
(pg. 495
-506
) Catapano AL, Reiner Z, De Backer G, et al. ESC/EAS guidelines for the management of dyslipidaemias; The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis. 2011;217(1):3–46.
,
ESC/EAS guidelines for the management of dyslipidaemias; The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
, Atherosclerosis.
, vol. 217
(pg. 3
-46
) Huxley RR, Barzi F, Lam TH, et al. Isolated low levels of high-density lipoprotein cholesterol are associated with an increased risk of coronary heart disease: An individual participant data meta-analysis of 23 studies in the Asia-Pacific region. Circulation. 2011;124(19):2056–2064.
,
Isolated low levels of high-density lipoprotein cholesterol are associated with an increased risk of coronary heart disease: An individual participant data meta-analysis of 23 studies in the Asia-Pacific region
, Circulation.
, vol. 124
(pg. 2056
-2064
) Cohn JN. Introduction to surrogate markers. Circulation. 2004;109(25 Suppl 1):IV20–21.
,
Introduction to surrogate markers
, Circulation.
, vol. 109
(pg. IV20
-21
) Cohn JN, Quyyumi AA, Hollenberg NK, Jamerson KA. Surrogate markers for cardiovascular disease: Functional markers. Circulation. 2004;109(25 Suppl 1):IV31–46.
,
Surrogate markers for cardiovascular disease: Functional markers
, Circulation.
, vol. 109
(pg. IV31
-46
) Greenland P, Alpert JS, Beller GA, et al. 2010 ACCF/ AHA guideline for assessment of cardiovascular risk in asymptomatic adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2010;56(25):50–103.
,
2010 ACCF/ AHA guideline for assessment of cardiovascular risk in asymptomatic adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
, J Am Coll Cardiol.
, vol. 56
(pg. 50
-103
) Lieberman JA, Hammond FM, Barringer TA, et al. Comparison of coronary artery calcification scores and National Cholesterol Education program guidelines for coronary heart disease risk assessment and treatment paradigms in individuals with chronic traumatic spinal cord injury. J Spinal Cord Med. 2011;34(2):233–240.
,
Comparison of coronary artery calcification scores and National Cholesterol Education program guidelines for coronary heart disease risk assessment and treatment paradigms in individuals with chronic traumatic spinal cord injury
, J Spinal Cord Med.
, vol. 34
(pg. 233
-240
) VanGilder C, MacFarlane G, Meyer S, Lachenbruch C. Body mass index, weight, and pressure ulcer prevalence: An analysis of the 2006–2007 International Pressure Ulcer Prevalence Surveys. J Nurs Care Qual. 2009;24(2):127–135.
,
Body mass index, weight, and pressure ulcer prevalence: An analysis of the 2006–2007 International Pressure Ulcer Prevalence Surveys
, J Nurs Care Qual.
, vol. 24
(pg. 127
-135
) Berg AO, Allan JD. Introducing the third US Preventive Services Task Force. Am J Prev Med. 2001;20(3 Suppl):3–4.
,
Introducing the third US Preventive Services Task Force
, Am J Prev Med.
, vol. 20
(pg. 3
-4
) Ravnskov U. American College of Physicians guidelines on cholesterol screening. Ann Intern Med. 1996;125(12):1010–1011.
,
American College of Physicians guidelines on cholesterol screening
, Ann Intern Med.
, vol. 125
(pg. 1010
-1011
)
This content is only available as a PDF.
